Aptus Capital Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,723	Closed	-$1.08M	–	302
2018 Q4	$1.08M	Buy	+12,723	New	+$1.08M	0.28%	63